Health
Regeneron suspends Covid-19 antibody trial among sickest patients – Macau Business
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients…
-
Noosa News12 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News18 hours agoGood Charlotte are Touring Australia and New Zealand in 2026
-
Noosa News9 hours agoDavid’s neighbour died alone. He now knows what comes next
-
General11 hours agoACT family violence victims ‘waiting 3 or 4 days’ for help, inquiry hears